Treventis founders give invited lectures at WATOC

Treventis founders Donald Weaver and Christopher Barden are both invited speakers at the 12th Triennial Congress of the World Association of Theoretical and Computational Chemists (WATOC), which was rescheduled from summer 2020 due to the COVID-19 pandemic.

Dr. Barden will be speaking on Monday July 4 about “Computer-aided Design of Small Molecule Inhibitors of Oligomerization in Protein Misfolding Disease”, which is a showcase of the company’s Common Conformational Morphology technology and its applications.

Dr. Weaver will be presenting neuroinflammatory aspects of Alzheimer’s disease during his invited lecture Thursday July 7, on “The In Silico Search for an Endogenous Anti-Alzheimer’s Molecule”.

Treventis is pleased to be able to talk about its research at this long-awaited meeting.